Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
icosapent ethyl (vascepa) (1 trial)
Liver Diseases (Phase 2)
Short Bowel Syndrome (Phase 2)
Syndrome (Phase 2)
Trials (1 total)
Trial APIs (1 total)